Glycomacropeptide formula with amino acids and low phenylalanine

PBAC's latest decision on Glycomacropeptide formula with amino acids and low phenylalanine: Recommended (2022). Considered for Treatment of phenylketonuria (PKU) in children from 3 years of age, and adults.

Eligible population

Children from 3 years of age, and adults with phenylketonuria (PKU).

Therapy area

Metabolic

Line of therapy

Not applicable

Evidence base

Cost-minimisation

Primary endpoint

Cost-minimisation

Comparator

PKU Restore (main comparator); also Phlexy-10, PKU Easy Tablet, PKU Easy Microtabs

Economic model

Cost-minimisation

ICER note

Cost-minimisation analysis; no ICER calculated. Same price per gram protein equivalent ($0.795) as main comparator PKU Restore.

Similar precedents

• Glycomacropeptide formula with amino acids, vitamins, minerals, trace elements, carbohydrate, fat and low phenylalanine
  similarity 0.90
• Glycomacropeptide formula with docosahexaenoic acid with low phenylalanine
  similarity 0.90
• Glycomacropeptide formula with docosahexaenoic acid and low phenylalanine
  similarity 0.87
• Glycomacropeptide and essential amino acids
  similarity 0.84
• Amino acid formula with fat, carbohydrate, vitamins and minerals without phenylalanine
  similarity 0.80
• Amino acid formula with carbohydrate, vitamins, minerals and trace elements without phenylalanine
  similarity 0.80